Skip to main content
The Markets by Proactive
Go to Proactive Australia

Archive

Memphasys achieves quality certification for medical devices and diagnostics

Memphasys achieves quality certification for medical devices and diagnostics

Memphasys Ltd (ASX:MEM)'s Alison Coutts talks to Ky Chow about the compliance sign-off process for the company's medical devices and diagnostic kits and reveals a bit about the company's IVF product pipeline, including a horse pregnancy prediction kit for racehorses. Coutts says there is "massive demand" for such a product in the racing industry.